Small molecule · Agonist of opioid receptors · developed by Pfizer
Diphenoxylate is a piperidine derivative chemically related to meperidine that acts on opioid receptors in the gastrointestinal tract to decrease motility and prevent diarrhea.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Feb 23, 2026). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT03094052 | Phase 2 | HER2-positive Breast Cancer | Completed | PBYI |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Breast AdenocarcinomaHER2-positive Breast CancerStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7Stage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7
Updated Oct 3, 2026.